Deterioro neuropsicológico reversible asociado a zonisamida en un paciente pediátrico con esclerosis tuberosa

Fournier Del Castillo, M Concepción; Melero Llorente, Javier; Blanco Beregaña, Miriam; Robles Bermejo, Fernando; Budke, Marcelo; García Fernández, Marta; García Peñas, Juan José; Pérez Jiménez, M Ángeles.
Rev. neurol. (Ed. impr.) ; 60(2): 75-80, 16 ene., 2015. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-131719

Documentos relacionados

  1. The people behind the papers - Jiajia Ye and Qiang Sun.
  2. Cancer Predisposition Syndromes in Neuro-oncology.
  3. Tuberous Sclerosis: A Rare Disease with an Orphan Complex.
  4. The longitudinal evolution of cerebral blood flow in children with tuberous sclerosis assessed by arterial spin labeling magnetic resonance imaging may be related to cognitive performance.
  5. Global and intertuberal epileptic networks in tuberous sclerosis based on stereoelectroencephalographic (sEEG) findings: a quantitative EEG analysis in pediatric subjects and surgical implications.
  6. Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on <sup>18</sup>F-FDG PET: an 8-year single-centre study.
  7. The epilepsy-autism spectrum disorder phenotype in the era of molecular genetics and precision therapy.
  8. Early therapeutic intervention guided by electroencephalography surveillance in infants with tuberous sclerosis complex.
  9. Prenatal diagnosis and intervention improve developmental outcomes and epilepsy prognosis in children with tuberous sclerosis complex.
  10. Tuberous Sclerosis Complex.